Form S-1/A N2OFF, Inc.
http://archive.fast-edgar.com/20250214/A822M22CZ22RBTOX222D2ZY2IKGDRZ22Z272
Filed on: February 14, 2025
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi reiterates Sell rating on Moderna with $80 price target
- Innovent's gastric cancer drug meets survival endpoints in phase 3 trial
- Innovent's gastric cancer drug meets survival endpoints in phase 3 trial
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
S1Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share